Jim Smeeding is President of TPG National Payor Roundtable (TPG-NPRT), an educational company that brings healthcare industry product and service offerings to managed care decision makers. Education and access are the key attributes that TPG-NPRT offers client customers and payor medical decision makers.Jim also serves as President of four other healthcare industry companies: JestaRx Group, Digital Health Dialog, Edjudicate and Project Rx. The Jestarx Group is a data and educational resource company that works with pharmaceutical manufacturers. Digital Health Dialog is a patented mobile-phone tool that delivers instant, personally-targeted messages to patients at more convenient points in their therapy – making it far more likely that they fill prescriptions with your brand. Project Rx works with hospital pharmacies to assess, evaluate and improve quality, safety and efficiency of service delivery. Edjudicate is a private consultancy group that focuses on the unique needs of pharmaceutical-oriented customers.
Jim’s private clients represent the spectrum of pharmaceutical companies, medical device companies, diagnostic testing and all classes of pharmacy affairs: hospital, retail, chain, managed care, academic and research. Jim’s broad expertise has allowed his clients to understand, approach and impact pharmacy affairs from product selection through to the value proposition as well as professional communications, patient communications and safety.
Jim is a founder of the Center for Pharmacoeconomic Studies at the University of Texas College of Pharmacy. He is also a founder of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and served as their second president. Over the past 39 years the focus of his practice has been in hospital pharmacy, clinical services design, home infusion therapy, managed care services, and disease management.
Jim has a pharmacy degree from the University of Buffalo and an MBA from the University of Texas.